Group | IL-1 (ng/mL) | IL-6 (ng/mL) | TNF-α (ng/mL) | |||
---|---|---|---|---|---|---|
Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
Monotherapy group (n = 50) | 47.28 ± 8.25 | 31.45 ± 5.08* | 45.37 ± 6.38 | 29.73 ± 5.04* | 53.26 ± 9.06 | 33.79 ± 6.58* |
Combination group (n = 56) | 49.53 ± 8.32 | 23.74 ± 5.21* | 44.56 ± 6.12 | 20.55 ± 4.82* | 54.57 ± 8.85 | 25.38 ± 6.14* |
t | 1.395 | 7.696 | 0.667 | 9.580 | 0.752 | 6.806 |
P value | 0.166 | < 0.001 | 0.506 | < 0.001 | 0.454 | < 0.001 |